Cargando…
Pharmacokinetic implications leading to marked valproic acid level-drop during COVID-19 treatment
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832790/ https://www.ncbi.nlm.nih.gov/pubmed/33418460 http://dx.doi.org/10.1016/j.psychres.2020.113701 |
| _version_ | 1783641913809698816 |
|---|---|
| author | Bojdani, Ermal |
| author_facet | Bojdani, Ermal |
| author_sort | Bojdani, Ermal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7832790 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78327902021-01-26 Pharmacokinetic implications leading to marked valproic acid level-drop during COVID-19 treatment Bojdani, Ermal Psychiatry Res Letter to the Editor Elsevier B.V. 2021-02 2020-12-31 /pmc/articles/PMC7832790/ /pubmed/33418460 http://dx.doi.org/10.1016/j.psychres.2020.113701 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Bojdani, Ermal Pharmacokinetic implications leading to marked valproic acid level-drop during COVID-19 treatment |
| title | Pharmacokinetic implications leading to marked valproic acid level-drop during COVID-19 treatment |
| title_full | Pharmacokinetic implications leading to marked valproic acid level-drop during COVID-19 treatment |
| title_fullStr | Pharmacokinetic implications leading to marked valproic acid level-drop during COVID-19 treatment |
| title_full_unstemmed | Pharmacokinetic implications leading to marked valproic acid level-drop during COVID-19 treatment |
| title_short | Pharmacokinetic implications leading to marked valproic acid level-drop during COVID-19 treatment |
| title_sort | pharmacokinetic implications leading to marked valproic acid level-drop during covid-19 treatment |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832790/ https://www.ncbi.nlm.nih.gov/pubmed/33418460 http://dx.doi.org/10.1016/j.psychres.2020.113701 |
| work_keys_str_mv | AT bojdaniermal pharmacokineticimplicationsleadingtomarkedvalproicacidleveldropduringcovid19treatment |